The morbidity and utility of periaortic radiotherapy in cervical carcinoma

Roger Potish, Leon Adcock, Thomas Jones, Seymour Levitt, Konald Prem, John Savage, Leo Twiggs

Research output: Contribution to journalArticle

41 Scopus citations

Abstract

From 1971 through 1981, 81 women received 4350 to 5075 rad to the periaortic lymph nodes as part of their primary management for carcinoma of the uterine cervix. While two patients developed chronic small bowel damage, only one required surgical intervention. Five-year disease-free survival was 40%. Approximately one-third of the first recurrences were within the pelvic and periaortic radiation portals, with the remainder in the lungs, liver, bones, abdomen, and supraclavicular lymph nodes. Radiation dose and volume guidelines are presented in order to minimize enteric morbidity.

Original languageEnglish (US)
Pages (from-to)1-9
Number of pages9
JournalGynecologic oncology
Volume15
Issue number1
DOIs
StatePublished - Feb 1983

ASJC Scopus subject areas

  • Oncology
  • Obstetrics and Gynecology

Fingerprint Dive into the research topics of 'The morbidity and utility of periaortic radiotherapy in cervical carcinoma'. Together they form a unique fingerprint.

  • Cite this

    Potish, R., Adcock, L., Jones, T., Levitt, S., Prem, K., Savage, J., & Twiggs, L. (1983). The morbidity and utility of periaortic radiotherapy in cervical carcinoma. Gynecologic oncology, 15(1), 1-9. https://doi.org/10.1016/0090-8258(83)90110-5